Literature DB >> 3948470

Pharmacokinetics and pharmacodynamics of glucocorticoid suspensions after intra-articular administration.

H Derendorf, H Möllmann, A Grüner, D Haack, G Gyselby.   

Abstract

Triamcinolone acetonide, triamcinolone hexacetonide, and a combination of betamethasone phosphate and acetate were given intra-articularly in different doses. Plasma levels of the steroids were measured and pharmacokinetic parameters were calculated. As a pharmacodynamic parameter for systemic steroid activity, plasma hydrocortisone levels were monitored for 3 weeks. Results indicate complete absorption from the site of injection over a period of 2 to 3 weeks. Because of its lower solubility, triamcinolone hexacetonide is absorbed slower than triamcinolone acetonide, thus maintaining synovial levels for a longer time and creating lower systemic corticoid levels. Endogenous hydrocortisone suppression correlated with exogenous steroid levels. Threshold concentrations for maximum suppression were determined.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3948470     DOI: 10.1038/clpt.1986.45

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  59 in total

Review 1.  Nanotherapeutic approaches for the treatment of rheumatoid arthritis.

Authors:  Christine T N Pham
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2011-08-11

Review 2.  Flip-flop pharmacokinetics--delivering a reversal of disposition: challenges and opportunities during drug development.

Authors:  Jaime A Yáñez; Connie M Remsberg; Casey L Sayre; M Laird Forrest; Neal M Davies
Journal:  Ther Deliv       Date:  2011-05

3.  Orbital steroid injections.

Authors:  R A Goldberg
Journal:  Br J Ophthalmol       Date:  2004-11       Impact factor: 4.638

Review 4.  Intra-articular and soft tissue injections, a systematic review of relative efficacy of various corticosteroids.

Authors:  Neha Garg; Lisa Perry; Atul Deodhar
Journal:  Clin Rheumatol       Date:  2014-03-21       Impact factor: 2.980

5.  Exogenous steroid-induced hypoadrenalism in a person living with HIV caused by a drug-drug interaction between cobicistat and intrabursal triamcinolone.

Authors:  Navnit Makaram; Clark D Russell; Simon Benedict Roberts; Jarrad Stevens; Gavin Macpherson
Journal:  BMJ Case Rep       Date:  2018-12-14

6.  Injecting epidural and intra-articular triamcinolone in HIV-positive patients on ritonavir: beware of iatrogenic Cushing's syndrome.

Authors:  M Maviki; P Cowley; H Marmery
Journal:  Skeletal Radiol       Date:  2012-11-15       Impact factor: 2.199

7.  A high dose (up to 200 mg) tolerance and efficacy study of intra-articular rimexolone (Org 6216) in rheumatoid synovitis of the knee.

Authors:  G Gevers; J Dequeker; M van Holsbeeck; E van Vliet-Daskalopoulou
Journal:  Clin Rheumatol       Date:  1994-03       Impact factor: 2.980

8.  Iatrogenic Cushing syndrome after epidural triamcinolone injections in an HIV type 1-infected patient receiving therapy with ritonavir-lopinavir.

Authors:  Roshan Ramanathan; Alice K Pau; Kristin H Busse; Marina Zemskova; Lynnette Nieman; Richard Kwan; Jean H Hammer; JoAnn M Mican; Frank Maldarelli
Journal:  Clin Infect Dis       Date:  2008-12-15       Impact factor: 9.079

Review 9.  Evaluating intra-articular drug delivery for the treatment of osteoarthritis in a rat model.

Authors:  Kyle D Allen; Samuel B Adams; Lori A Setton
Journal:  Tissue Eng Part B Rev       Date:  2010-02       Impact factor: 6.389

10.  Adrenal suppression due to an interaction between ritonavir and injected triamcinolone: a case report.

Authors:  Kathryn Dort; Shetal Padia; Brian Wispelwey; Christopher C Moore
Journal:  AIDS Res Ther       Date:  2009-06-08       Impact factor: 2.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.